drugset
drugset / Trial / NCT03494907

A Study to Evaluate the Effects of Single-dose Seltorexant on Electrocardiogram Intervals in Healthy Adult Participants

NCT03494907 ↗

Phase 1 Completed 52 enrolled Janssen Research & Development, LLC
RandomizedCrossoverQuadruple-blindOther

Summary

The purpose of this study is to assess the effects of single dose seltorexant on QT/QTc intervals and electrocardiogram (ECG) morphology at therapeutic and supratherapeutic exposures in healthy adult participants.

Timeline

Start
2018-04-09
Primary completion
2018-08-13
Completion
2018-08-13

Drugs

EvaluationDrugModalityDoseRoute
Subject Moxifloxacin Small molecule — Oral
Subject Seltorexant Small molecule — Oral

Indications

No indication recorded.